Alembic Pharmaceuticals informs about disclosure

06 May 2024 Evaluate

Alembic Pharmaceuticals has informed that the Company has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for the inspection carried out by them at our Oncology (Injectable and Oral Solid) Formulation Facility (F-2) at Panelav from 28th February, 2024 to 8th March, 2024. With this, for all its USFDA facilities, EIRs are in place.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

677.25 6.75 (1.01%)
18-Mar-2026 14:13 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.20
Dr. Reddys Lab 1295.95
Cipla 1271.50
Zydus Lifesciences 901.90
Lupin 2310.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×